We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Criticizes AHRQ Comparative Studies For Potential Limits to Rx Access
Industry Criticizes AHRQ Comparative Studies For Potential Limits to Rx Access
February 3, 2006
Pharmaceutical and device manufacturers are concerned that the Agency for Healthcare Research and Quality’s (AHRQ) initiative to recommend preferred treatment options for a variety of health conditions could limit access to some medical therapies, especially if AHRQ focuses unduly on costs.